Design Therapeutics Inc.
DSGN | NASDAQ
$12.82
+$0.27 (+2.15%)
Sep 22, 2026, 10:49 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 16.86M | 22.56M | 21.2M | 26.5M | 298.57M | 2.38M |
Short-Term Investments | 202.99M | 222.91M | 260.6M | 303.89M | 85.5M | 33.71M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 427K | 430K | 459K | n/a | 212K |
Receivables | 1.68M | 1.26M | 1.43M | 1.12M | 110K | 10K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | 25K |
Total Current Assets | 223.78M | 248.04M | 284.58M | 335.12M | 385.44M | 36.23M |
Property-Plant & Equipment | 2.42M | 3.63M | 4.63M | 5.56M | 5.12M | 71K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.42M | 4.05M | 5.06M | 6.02M | 5.12M | 283K |
Total Assets | 226.2M | 252.09M | 289.64M | 341.14M | 390.56M | 36.52M |
Account Payables | 2.31M | 2.19M | 1.94M | 3.03M | 1.62M | 1.4M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.63M | 3.58M | 4.03M | 3.54M | 2.15M | 565K |
Total Current Liabilities | 13.06M | 8.46M | 9.62M | 10.78M | 5.28M | 2.33M |
Long-Term Debt | 645K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 45.5M |
Total Long-Term Liabilities | 645K | 1.53M | 2.33M | 3.05M | 3.14M | 45.5M |
Total Liabilities | 13.7M | 10M | 11.96M | 13.83M | 8.43M | 47.83M |
Total Debt | 1.54M | 2.33M | 3.05M | 3.69M | 3.63M | n/a |
Book Value | 212.5M | 242.1M | 277.69M | 327.31M | 382.13M | -11.32M |
Book Value Per Share | 3.71 | 4.28 | 4.96 | 5.88 | 8.32 | -0.42 |
Common Stock | 6K | 6K | 6K | 6K | 6K | 1K |
Retained Earnings | -297.01M | -227.21M | -177.63M | -110.76M | -47.46M | -11.92M |
Comprehensive Income | 403K | 475K | 62K | -3.36M | -244K | 156K |
Shareholders Equity | 212.5M | 242.1M | 277.69M | 327.31M | 382.13M | -11.32M |
Total Investments | 202.99M | 222.91M | 260.6M | 303.89M | 85.5M | 33.71M |
Add to Watchlist
Select watchlists to add or remove DSGN